Press Release

Morepen Laboratories Limited ' Q3 FY24 EBITDA Surges by 151%, Net Profit Records a Remarkable 256% Growth

01-Feb-2024

Unaudited Financial Results and Limited Review Report for the Quarter ended 31st December, 2015

08-Feb-2016

Let's join hands to work Together